Detalhe da pesquisa
1.
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
Blood
; 137(10): 1416-1423, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33120429
2.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol
; 195(5): 757-763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581433
3.
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1099-1105, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165327
4.
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Cancer
; 126(10): 2279-2287, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32049359
5.
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Br J Haematol
; 190(4): 573-582, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314807
6.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1859-1868, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132455
7.
Navigating the perils and pitfalls throughout the consent process in hematopoietic cell transplantation.
Blood Rev
; 59: 101037, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577602
8.
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.
Blood Adv
; 6(3): 920-930, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861680
9.
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy.
Transplant Cell Ther
; 27(1): 55.e1-55.e7, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949754
10.
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation.
Transplant Cell Ther
; 27(1): 58-66, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956819
11.
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.
Transplant Cell Ther
; 27(11): 911.e1-911.e7, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34450333
12.
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Blood Adv
; 5(18): 3528-3539, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496026
13.
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.
JAMA Oncol
; 6(7): 1011-1018, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496525
14.
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.
Blood Cancer J
; 9(12): 97, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796726
15.
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL.
Blood Adv
; 3(3): 360-369, 2019 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723110
16.
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis.
J Hematol Oncol
; 12(1): 6, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630534
17.
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.
Blood Adv
; 2(8): 933-940, 2018 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685953
18.
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.
Blood Cancer J
; 11(4): 82, 2021 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33927193
19.
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma-Reply.
JAMA Oncol
; 6(12): 1984, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151256